Brief: Sinomab Bioscience Says Hainan Haiyao Co. To Purchase 6.8 Mln Shares Of Co
28/09/2020 02:36
Sept 28 (Reuters) - SinoMab BioScience Ltd 3681.HK :
* HAINAN HAIYAO CO. TO PURCHASE 6.8 MILLION SHARES OF CO AT
RMB2.777 EACH FROM FORBEST CAPITAL INVESTMENT GROUP
Source text for Eikon: ID:nHKS6Xv7qZ
Further company coverage: 3681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinomab Bioscience
See all newsBrief: Sinomab Bioscience Posts HY Loss Of RMB127.4 Million
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience